Table 1.
Demographic and surgical details for Crohn’s disease patients with first resections in years 1995-2000 (cohort A) and years 2005-2010 (cohort B)
| Cohort A 1995-2000 (n = 85) | Cohort B 2005-2010 (n = 114) | P value | |
| Age | 33 (± 12.1) | 31.5 (±13.9) | 0.440 |
| Gender (M/F) | 30.6 (26)/69.4 (59) | 54.4 (62)/ 45.6 (52) | 0.001 |
| Montreal classification | |||
| Age at diagnosis (A1/A2/A3) | 9.8%/74.4%/15.9% | 21.1%/65.8%/13.2% | 0.110 |
| Disease behavior (B1/B2/B3) | 38.8%/31.8%/29.4% | 12.3%/45.6%/42.1% | < 0.0001 |
| Disease location (L1/L2/L3) | 32.9%/28.2%/38.8% | 26.3%/14.9%/58.8% | 0.010 |
| Medication exposure | |||
| 5-ASA | 53.6 (45) | 29.8 (34) | 0.001 |
| CS | 69.1 (58) | 75.4 (86) | 0.320 |
| IM | 21.4 (18) | 56.1 (64) | < 0.0001 |
| Surgical details | |||
| Time from diagnosis to surgery (mo) | 72 ± 83.8 | 72 ± 89.5 | 0.710 |
| Amount of small bowel resected (cm) | 21 ± 12.6 | 23 ± 17.5 | 0.820 |
| Length of hospital stay (d) | 10 ± 16.7 | 9 ± 8.0 | 0.050 |
Data are expressed as absolute numbers (percentage) or mean ± SD. 5-ASA: 5-aminosalysilic acid; CS: Corticosteroid; IM: Immunomodulator; M: Male; F: Female.